Two CML patients who subsequently developed features of essential thrombocythemia with JAK2-V617F mutation while in complete cytogenetic remission after treatment with imatinib mesylate

Author： Lee Yoo  

Publisher： Springer Publishing Company

ISSN： 0925-5710

Source： International Journal of Hematology, Vol.97, Iss.6, 2013-06, pp. : 804-807

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Impact of JAK2V617F mutation on thrombosis and myeloid transformation in essential thrombocythemia: a multivariate analysis by Cox regression in 141 patients

By Chim C. S.   Sim J. P.   Chan C. C.   Kho B. C.   Chan J. C.   Wong L. G.   Law M.   Liang R.   Kwong Y. L.  

Hematology, Vol. 15, Iss. 4, 2010-08 ,pp. : 187-192

Maney Publishing

Access to resources Recommend Favorite

Different involvement of the megakaryocytic lineage by the JAK2V617F mutation in Polycythemia vera, essential thrombocythemia and chronic idiopathic myelofibrosis

By Hussein Kais   Brakensiek Kai   Buesche Guntram   Buhr Thomas   Wiese Birgitt   Kreipe Hans   Bock Oliver  

Annals of Hematology, Vol. 86, Iss. 4, 2007-04 ,pp. : 245-253

Springer Publishing Company

Access to resources Recommend Favorite

JAK2V617F positive early stage myeloproliferative disease (essential thrombocythemia) as the cause of portal vein thrombosis in two middle-aged women: therapeutic implications in view of the literature

By Michiels J.   Commandeur S.   Hoogenboom G.   Wegman J.   Scholten L.   Rijssel R.   Raeve H.  

Annals of Hematology, Vol. 86, Iss. 11, 2007-11 ,pp. : 793-800

Springer Publishing Company

Access to resources Recommend Favorite

Reemergence of JAK2 V617F clone heralds extramedullary leukemia relapse after BMT for transformed essential thrombocytosis

By Au W.   Fung A.   Lie A.   Lam K.   Lam C.   Kwong Y.  

Annals of Hematology, Vol. 86, Iss. 2, 2007-02 ,pp. : 145-147

Springer Publishing Company

Access to resources Recommend Favorite

Clinical significance of V617F mutation of the JAK2 gene in patients with chronic myeloproliferative disorders

By Basquiera Ana L.   Soria Néstor W.   Ryser Ricardo   Salguero Miriam   Moiraghi Beatriz   Sackmann Federico   Sturich Ana G.   Borello Adriana   Berretta Adriana   Bonafé Miriam   Barral José Moreno   Palazzo Emilio D.   García Juan J.  

Hematology, Vol. 14, Iss. 6, 2009-12 ,pp. : 323-330

Maney Publishing

Access to resources Recommend Favorite